{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,8]],"date-time":"2026-07-08T02:40:42Z","timestamp":1783478442689,"version":"3.55.0"},"reference-count":61,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2023,7,28]],"date-time":"2023-07-28T00:00:00Z","timestamp":1690502400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2023,7,28]],"date-time":"2023-07-28T00:00:00Z","timestamp":1690502400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81870255"],"award-info":[{"award-number":["81870255"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100019540","name":"Science Fund for Distinguished Young Scholars of Zhejiang Province","doi-asserted-by":"publisher","award":["LY21H020001"],"award-info":[{"award-number":["LY21H020001"]}],"id":[{"id":"10.13039\/501100019540","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100017594","name":"Medical Science and Technology Project of Zhejiang Province","doi-asserted-by":"publisher","award":["2021KY306"],"award-info":[{"award-number":["2021KY306"]}],"id":[{"id":"10.13039\/501100017594","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100005315","name":"Natural Science Foundation of Ningbo Municipality","doi-asserted-by":"publisher","award":["2021J296"],"award-info":[{"award-number":["2021J296"]}],"id":[{"id":"10.13039\/501100005315","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Clin Rheumatol"],"published-print":{"date-parts":[[2024,1]]},"DOI":"10.1007\/s10067-023-06693-7","type":"journal-article","created":{"date-parts":[[2023,7,28]],"date-time":"2023-07-28T13:01:47Z","timestamp":1690549307000},"page":"533-541","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":9,"title":["Immune-mediated inflammatory diseases and the risk of valvular heart disease: a Mendelian randomization study"],"prefix":"10.1007","volume":"43","author":[{"given":"Dihui","family":"Cai","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zequn","family":"Zheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiale","family":"Hu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yin","family":"Fu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yongfei","family":"Song","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3573-8051","authenticated-orcid":false,"given":"Jiangfang","family":"Lian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,7,28]]},"reference":[{"issue":"12","key":"6693_CR1","doi-asserted-by":"crossref","first-page":"853","DOI":"10.1038\/s41569-021-00570-z","volume":"18","author":"S Coffey","year":"2021","unstructured":"Coffey S et al (2021) Global epidemiology of valvular heart disease. Nat Rev Cardiol 18(12):853\u2013864","journal-title":"Nat Rev Cardiol"},{"issue":"10","key":"6693_CR2","doi-asserted-by":"crossref","first-page":"680","DOI":"10.1038\/s41577-021-00603-1","volume":"21","author":"IB McInnes","year":"2021","unstructured":"McInnes IB, Gravallese EM (2021) Immune-mediated inflammatory disease therapeutics: past, present and future. Nat Rev Immunol 21(10):680\u2013686","journal-title":"Nat Rev Immunol"},{"issue":"1","key":"6693_CR3","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1136\/heartjnl-2019-316378","volume":"108","author":"R Agca","year":"2022","unstructured":"Agca R, Smulders Y, Nurmohamed M (2022) Cardiovascular disease risk in immune-mediated inflammatory diseases: recommendations for clinical practice. Heart 108(1):73\u201379","journal-title":"Heart"},{"key":"6693_CR4","doi-asserted-by":"crossref","first-page":"1056400","DOI":"10.3389\/fimmu.2022.1056400","volume":"13","author":"SY Pan","year":"2022","unstructured":"Pan SY et al (2022) Cardiac damage in autoimmune diseases: target organ involvement that cannot be ignored. Front Immunol 13:1056400","journal-title":"Front Immunol"},{"issue":"1","key":"6693_CR5","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1007\/s11882-014-0491-z","volume":"15","author":"ER Breed","year":"2015","unstructured":"Breed ER, Binstadt BA (2015) Autoimmune valvular carditis. Curr Allergy Asthma Rep 15(1):491","journal-title":"Curr Allergy Asthma Rep"},{"key":"6693_CR6","unstructured":"Gartshteyn Y et al (2022) Inflammatory and thrombotic valvulopathies in autoimmune disease. Heart heartjnl-2021-319603"},{"issue":"8","key":"6693_CR7","doi-asserted-by":"crossref","first-page":"1133","DOI":"10.1002\/sim.3034","volume":"27","author":"DA Lawlor","year":"2008","unstructured":"Lawlor DA et al (2008) Mendelian randomization: using genes as instruments for making causal inferences in epidemiology. Stat Med 27(8):1133\u20131163","journal-title":"Stat Med"},{"issue":"1","key":"6693_CR8","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1093\/ije\/dyg070","volume":"32","author":"GD Smith","year":"2003","unstructured":"Smith GD, Ebrahim S (2003) \u2018Mendelian randomization\u2019: can genetic epidemiology contribute to understanding environmental determinants of disease? Int J Epidemiol 32(1):1\u201322","journal-title":"Int J Epidemiol"},{"key":"6693_CR9","doi-asserted-by":"crossref","unstructured":"Hemani G et al (2018) The MR-Base platform supports systematic causal inference across the human phenome. Elife7:e34408","DOI":"10.7554\/eLife.34408"},{"key":"6693_CR10","doi-asserted-by":"crossref","first-page":"k601","DOI":"10.1136\/bmj.k601","volume":"362","author":"NM Davies","year":"2018","unstructured":"Davies NM, Holmes MV, Smith GD (2018) Reading Mendelian randomisation studies: a guide, glossary, and checklist for clinicians. Bmj 362:k601","journal-title":"Bmj"},{"issue":"12","key":"6693_CR11","doi-asserted-by":"crossref","first-page":"1457","DOI":"10.1038\/ng.3434","volume":"47","author":"J Bentham","year":"2015","unstructured":"Bentham J et al (2015) Genetic association analyses implicate aberrant regulation of innate and adaptive immunity genes in the pathogenesis of systemic lupus erythematosus. Nat Genet 47(12):1457\u20131464","journal-title":"Nat Genet"},{"issue":"5","key":"6693_CR12","doi-asserted-by":"crossref","first-page":"558","DOI":"10.1136\/annrheumdis-2020-219065","volume":"80","author":"E Ha","year":"2021","unstructured":"Ha E, Bae SC, Kim K (2021) Large-scale meta-analysis across East Asian and European populations updated genetic architecture and variant-driven biology of rheumatoid arthritis, identifying 11 novel susceptibility loci. Ann Rheum Dis 80(5):558\u2013565","journal-title":"Ann Rheum Dis"},{"key":"6693_CR13","unstructured":"Multiple sclerosis genomic map implicates peripheral immune cells and microglia in susceptibility. Science 2019. 365(6460):eaav7188"},{"issue":"7","key":"6693_CR14","doi-asserted-by":"crossref","first-page":"730","DOI":"10.1038\/ng.2667","volume":"45","author":"A Cortes","year":"2013","unstructured":"Cortes A et al (2013) Identification of multiple risk variants for ankylosing spondylitis through high-density genotyping of immune-related loci. Nat Genet 45(7):730\u2013738","journal-title":"Nat Genet"},{"issue":"12","key":"6693_CR15","doi-asserted-by":"crossref","first-page":"1341","DOI":"10.1038\/ng.2467","volume":"44","author":"LC Tsoi","year":"2012","unstructured":"Tsoi LC et al (2012) Identification of 15 new psoriasis susceptibility loci highlights the role of innate immunity. Nat Genet 44(12):1341\u20131348","journal-title":"Nat Genet"},{"issue":"2","key":"6693_CR16","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1038\/ng.3760","volume":"49","author":"KM de Lange","year":"2017","unstructured":"de Lange KM et al (2017) Genome-wide association study implicates immune activation of multiple integrin genes in inflammatory bowel disease. Nat Genet 49(2):256\u2013261","journal-title":"Nat Genet"},{"issue":"2","key":"6693_CR17","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1038\/s41588-018-0307-5","volume":"51","author":"M Liu","year":"2019","unstructured":"Liu M et al (2019) Association studies of up to 1.2 million individuals yield new insights into the genetic etiology of tobacco and alcohol use. Nat Genet 51(2):237\u2013244","journal-title":"Nat Genet"},{"issue":"5","key":"6693_CR18","doi-asserted-by":"crossref","first-page":"526","DOI":"10.1038\/ng.2247","volume":"44","author":"JP Bradfield","year":"2012","unstructured":"Bradfield JP et al (2012) A genome-wide association meta-analysis identifies new childhood obesity loci. Nat Genet 44(5):526\u2013531","journal-title":"Nat Genet"},{"issue":"3","key":"6693_CR19","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1161\/CIRCRESAHA.117.312086","volume":"122","author":"P van der Harst","year":"2018","unstructured":"van der Harst P, Verweij N (2018) Identification of 64 novel genetic loci provides an expanded view on the genetic architecture of coronary artery disease. Circ Res 122(3):433\u2013443","journal-title":"Circ Res"},{"issue":"22","key":"6693_CR20","doi-asserted-by":"crossref","first-page":"4851","DOI":"10.1093\/bioinformatics\/btz469","volume":"35","author":"MA Kamat","year":"2019","unstructured":"Kamat MA et al (2019) PhenoScanner V2: an expanded tool for searching human genotype-phenotype associations. Bioinformatics 35(22):4851\u20134853","journal-title":"Bioinformatics"},{"issue":"3","key":"6693_CR21","doi-asserted-by":"crossref","first-page":"755","DOI":"10.1093\/ije\/dyr036","volume":"40","author":"S Burgess","year":"2011","unstructured":"Burgess S, Thompson SG (2011) Avoiding bias from weak instruments in Mendelian randomization studies. Int J Epidemiol 40(3):755\u2013764","journal-title":"Int J Epidemiol"},{"issue":"4","key":"6693_CR22","doi-asserted-by":"crossref","first-page":"e0120758","DOI":"10.1371\/journal.pone.0120758","volume":"10","author":"H Shim","year":"2015","unstructured":"Shim H et al (2015) A multivariate genome-wide association analysis of 10 LDL subfractions, and their response to statin treatment, in 1868 Caucasians. PLoS One 10(4):e0120758","journal-title":"PLoS One"},{"issue":"5","key":"6693_CR23","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1038\/s41588-018-0099-7","volume":"50","author":"M Verbanck","year":"2018","unstructured":"Verbanck M et al (2018) Detection of widespread horizontal pleiotropy in causal relationships inferred from Mendelian randomization between complex traits and diseases. Nat Genet 50(5):693\u2013698","journal-title":"Nat Genet"},{"issue":"4","key":"6693_CR24","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1002\/gepi.21965","volume":"40","author":"J Bowden","year":"2016","unstructured":"Bowden J et al (2016) Consistent estimation in Mendelian randomization with some invalid instruments using a weighted median estimator. Genet Epidemiol 40(4):304\u2013314","journal-title":"Genet Epidemiol"},{"issue":"2","key":"6693_CR25","doi-asserted-by":"crossref","first-page":"512","DOI":"10.1093\/ije\/dyv080","volume":"44","author":"J Bowden","year":"2015","unstructured":"Bowden J, Smith GD, Burgess S (2015) Mendelian randomization with invalid instruments: effect estimation and bias detection through Egger regression. Int J Epidemiol 44(2):512\u201325","journal-title":"Int J Epidemiol"},{"issue":"2","key":"6693_CR26","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1097\/MED.0000000000000471","volume":"26","author":"HY Chen","year":"2019","unstructured":"Chen HY, Engert JC, Thanassoulis G (2019) Risk factors for valvular calcification. Curr Opin Endocrinol Diabetes Obes 26(2):96\u2013102","journal-title":"Curr Opin Endocrinol Diabetes Obes"},{"issue":"10","key":"6693_CR27","doi-asserted-by":"crossref","first-page":"e0202105","DOI":"10.1371\/journal.pone.0202105","volume":"13","author":"T Burkard","year":"2018","unstructured":"Burkard T et al (2018) The heart in systemic lupus erythematosus - a comprehensive approach by cardiovascular magnetic resonance tomography. PLoS One 13(10):e0202105","journal-title":"PLoS One"},{"key":"6693_CR28","doi-asserted-by":"crossref","first-page":"107466","DOI":"10.1016\/j.intimp.2021.107466","volume":"94","author":"X Lu","year":"2021","unstructured":"Lu X et al (2021) Patients with systemic lupus erythematosus face a high risk of cardiovascular disease: a systematic review and meta-analysis. Int Immunopharmacol 94:107466","journal-title":"Int Immunopharmacol"},{"issue":"3","key":"6693_CR29","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1016\/j.amjms.2017.07.007","volume":"355","author":"D Ruiz","year":"2018","unstructured":"Ruiz D, Oates JC, Kamen DL (2018) Antiphospholipid antibodies and heart valve disease in systemic lupus erythematosus. Am J Med Sci 355(3):293\u2013298","journal-title":"Am J Med Sci"},{"issue":"7","key":"6693_CR30","doi-asserted-by":"crossref","first-page":"636","DOI":"10.1016\/j.amjmed.2007.01.024","volume":"120","author":"I Moyssakis","year":"2007","unstructured":"Moyssakis I et al (2007) Libman-Sacks endocarditis in systemic lupus erythematosus: prevalence, associations, and evolution. Am J Med 120(7):636\u2013642","journal-title":"Am J Med"},{"issue":"3","key":"6693_CR31","doi-asserted-by":"crossref","first-page":"460","DOI":"10.1002\/art.21162","volume":"53","author":"F Perez-Villa","year":"2005","unstructured":"Perez-Villa F et al (2005) Severe valvular regurgitation and antiphospholipid antibodies in systemic lupus erythematosus: a prospective, long-term, followup study. Arthritis Rheum 53(3):460\u2013467","journal-title":"Arthritis Rheum"},{"issue":"12","key":"6693_CR32","doi-asserted-by":"crossref","first-page":"1134","DOI":"10.1016\/j.autrev.2016.09.007","volume":"15","author":"F Vivero","year":"2016","unstructured":"Vivero F et al (2016) Prevalence and predictors of valvular heart disease in patients with systemic lupus erythematosus. Autoimmun Rev 15(12):1134\u20131140","journal-title":"Autoimmun Rev"},{"issue":"5","key":"6693_CR33","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1111\/eci.12744","volume":"47","author":"A Watad","year":"2017","unstructured":"Watad A et al (2017) The association between systemic lupus erythematosus and valvular heart disease: an extensive data analysis. Eur J Clin Invest 47(5):366\u2013371","journal-title":"Eur J Clin Invest"},{"issue":"34","key":"6693_CR34","doi-asserted-by":"crossref","first-page":"3388","DOI":"10.1093\/eurheartj\/ehab454","volume":"42","author":"MS Kim","year":"2021","unstructured":"Kim MS et al (2021) Association between adiposity and cardiovascular outcomes: an umbrella review and meta-analysis of observational and Mendelian randomization studies. Eur Heart J 42(34):3388\u20133403","journal-title":"Eur Heart J"},{"issue":"2","key":"6693_CR35","doi-asserted-by":"crossref","first-page":"75","DOI":"10.23736\/S0031-0808.19.03748-0","volume":"62","author":"M Correa-Rodr\u00edguez","year":"2020","unstructured":"Correa-Rodr\u00edguez M et al (2020) The impact of obesity on disease activity, damage accrual, inflammation markers and cardiovascular risk factors in systemic lupus erythematosus. Panminerva Med 62(2):75\u201382","journal-title":"Panminerva Med"},{"issue":"9","key":"6693_CR36","doi-asserted-by":"crossref","first-page":"831","DOI":"10.1007\/s10654-018-0374-z","volume":"33","author":"V Colpani","year":"2018","unstructured":"Colpani V et al (2018) Lifestyle factors, cardiovascular disease and all-cause mortality in middle-aged and elderly women: a systematic review and meta-analysis. Eur J Epidemiol 33(9):831\u2013845","journal-title":"Eur J Epidemiol"},{"issue":"10","key":"6693_CR37","doi-asserted-by":"crossref","first-page":"1514","DOI":"10.3899\/jrheum.190733","volume":"47","author":"MHY Chua","year":"2020","unstructured":"Chua MHY et al (2020) Association between cigarette smoking and systemic lupus erythematosus: an updated multivariate Bayesian metaanalysis. J Rheumatol 47(10):1514\u20131521","journal-title":"J Rheumatol"},{"issue":"7","key":"6693_CR38","doi-asserted-by":"crossref","first-page":"865","DOI":"10.1093\/oxfordjournals.eurheartj.a060602","volume":"15","author":"M Lindroos","year":"1994","unstructured":"Lindroos M et al (1994) Factors associated with calcific aortic valve degeneration in the elderly. Eur Heart J 15(7):865\u2013870","journal-title":"Eur Heart J"},{"key":"6693_CR39","doi-asserted-by":"crossref","first-page":"iv4","DOI":"10.1093\/rheumatology\/kel313","volume":"45 Suppl 4","author":"AE Voskuyl","year":"2006","unstructured":"Voskuyl AE (2006) The heart and cardiovascular manifestations in rheumatoid arthritis. Rheumatology (Oxford) 45 Suppl 4:iv4-7","journal-title":"Rheumatology (Oxford)"},{"issue":"5","key":"6693_CR40","doi-asserted-by":"crossref","first-page":"2031","DOI":"10.1016\/j.ijcard.2012.05.057","volume":"167","author":"S Corrao","year":"2013","unstructured":"Corrao S et al (2013) Heart involvement in rheumatoid arthritis: systematic review and meta-analysis. Int J Cardiol 167(5):2031\u20132038","journal-title":"Int J Cardiol"},{"issue":"1","key":"6693_CR41","doi-asserted-by":"crossref","first-page":"18","DOI":"10.7861\/clinmedicine.1-1-18","volume":"1","author":"G Kitas","year":"2001","unstructured":"Kitas G, Banks MJ, Bacon PA (2001) Cardiac involvement in rheumatoid disease. Clin Med (Lond) 1(1):18\u201321","journal-title":"Clin Med (Lond)"},{"issue":"2","key":"6693_CR42","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1213\/ANE.0b013e3181dd869b","volume":"111","author":"LF Hiratzka","year":"2010","unstructured":"Hiratzka LF et al (2010) 2010 ACCF\/AHA\/AATS\/ACR\/ASA\/SCA\/SCAI\/SIR\/STS\/SVM guidelines for the diagnosis and management of patients with thoracic aortic disease: Executive summary: a report of the American College of Cardiology Foundation\/American Heart Association Task Force on Practice Guidelines, American Association for Thoracic Surgery, American College of Radiology, American Stroke Association, Society of Cardiovascular Anesthesiologists, Society for Cardiovascular Angiography and Interventions, Society of Interventional Radiology, Society of Thoracic Surgeons, and Society for Vascular Medicine. Anesth Analg 111(2):279\u2013315","journal-title":"Anesth Analg"},{"issue":"6","key":"6693_CR43","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1007\/s11926-020-00898-4","volume":"22","author":"M Chetrit","year":"2020","unstructured":"Chetrit M, Khan MA, Kapadia S (2020) State of the art management of aortic valve disease in ankylosing spondylitis. Curr Rheumatol Rep 22(6):23","journal-title":"Curr Rheumatol Rep"},{"key":"6693_CR44","doi-asserted-by":"crossref","first-page":"1759720x2110216","DOI":"10.1177\/1759720X211021676","volume":"13","author":"WZ Siao","year":"2021","unstructured":"Siao WZ et al (2021) Increased risk of valvular heart disease in patients with ankylosing spondylitis: a nationwide population-based longitudinal cohort study. Ther Adv Musculoskelet Dis 13:1759720x211021676","journal-title":"Ther Adv Musculoskelet Dis"},{"issue":"3","key":"6693_CR45","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1177\/1352458514564485","volume":"21","author":"RA Marrie","year":"2015","unstructured":"Marrie RA et al (2015) A systematic review of the incidence and prevalence of cardiac, cerebrovascular, and peripheral vascular disease in multiple sclerosis. Mult Scler 21(3):318\u2013331","journal-title":"Mult Scler"},{"issue":"4","key":"6693_CR46","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1159\/000320245","volume":"35","author":"CF Christiansen","year":"2010","unstructured":"Christiansen CF et al (2010) Risk of arterial cardiovascular diseases in patients with multiple sclerosis: a population-based cohort study. Neuroepidemiology 35(4):267\u2013274","journal-title":"Neuroepidemiology"},{"issue":"10","key":"6693_CR47","doi-asserted-by":"crossref","first-page":"1336","DOI":"10.1177\/1352458513475833","volume":"19","author":"E Jadidi","year":"2013","unstructured":"Jadidi E, Mohammadi M, Moradi T (2013) High risk of cardiovascular diseases after diagnosis of multiple sclerosis. Mult Scler 19(10):1336\u20131340","journal-title":"Mult Scler"},{"issue":"6","key":"6693_CR48","doi-asserted-by":"crossref","first-page":"632","DOI":"10.1177\/147323000603400608","volume":"34","author":"I Biyik","year":"2006","unstructured":"Biyik I et al (2006) Echocardiographic and clinical abnormalities in patients with psoriasis. J Int Med Res 34(6):632\u2013639","journal-title":"J Int Med Res"},{"issue":"5","key":"6693_CR49","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1016\/j.semarthrit.2005.12.002","volume":"35","author":"C Gonzalez-Juanatey","year":"2006","unstructured":"Gonzalez-Juanatey C et al (2006) Lack of echocardiographic and Doppler abnormalities in psoriatic arthritis patients without clinically evident cardiovascular disease or classic atherosclerosis risk factors. Semin Arthritis Rheum 35(5):333\u2013339","journal-title":"Semin Arthritis Rheum"},{"issue":"Suppl 2","key":"6693_CR50","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1111\/j.1468-3083.2009.03564.x","volume":"24","author":"S Prey","year":"2010","unstructured":"Prey S et al (2010) Cardiovascular risk factors in patients with plaque psoriasis: a systematic review of epidemiological studies. J Eur Acad Dermatol Venereol 24(Suppl 2):23\u201330","journal-title":"J Eur Acad Dermatol Venereol"},{"issue":"12","key":"6693_CR51","doi-asserted-by":"crossref","first-page":"1150.e1","DOI":"10.1016\/j.amjmed.2009.06.021","volume":"122","author":"AB Gottlieb","year":"2009","unstructured":"Gottlieb AB, Dann F (2009) Comorbidities in patients with psoriasis. Am J Med 122(12):1150.e1\u20139","journal-title":"Am J Med"},{"issue":"4","key":"6693_CR52","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1001\/archdermatol.2009.48","volume":"145","author":"AA Qureshi","year":"2009","unstructured":"Qureshi AA et al (2009) Psoriasis and the risk of diabetes and hypertension: a prospective study of US female nurses. Arch Dermatol 145(4):379\u2013382","journal-title":"Arch Dermatol"},{"issue":"1","key":"6693_CR53","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1016\/j.atherosclerosis.2012.06.068","volume":"224","author":"NN Mehta","year":"2012","unstructured":"Mehta NN et al (2012) Abnormal lipoprotein particles and cholesterol efflux capacity in patients with psoriasis. Atherosclerosis 224(1):218\u2013221","journal-title":"Atherosclerosis"},{"issue":"Suppl 3","key":"6693_CR54","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1111\/jdv.12163","volume":"27","author":"C Horreau","year":"2013","unstructured":"Horreau C et al (2013) Cardiovascular morbidity and mortality in psoriasis and psoriatic arthritis: a systematic literature review. J Eur Acad Dermatol Venereol 27(Suppl 3):12\u201329","journal-title":"J Eur Acad Dermatol Venereol"},{"issue":"2","key":"6693_CR55","doi-asserted-by":"crossref","first-page":"e000062","DOI":"10.1161\/JAHA.113.000062","volume":"2","author":"EJ Armstrong","year":"2013","unstructured":"Armstrong EJ, Harskamp CT, Armstrong AW (2013) Psoriasis and major adverse cardiovascular events: a systematic review and meta-analysis of observational studies. J Am Heart Assoc 2(2):e000062","journal-title":"J Am Heart Assoc"},{"issue":"9","key":"6693_CR56","doi-asserted-by":"crossref","first-page":"2189","DOI":"10.1038\/jid.2015.87","volume":"135","author":"R Parisi","year":"2015","unstructured":"Parisi R et al (2015) Psoriasis and the risk of major cardiovascular events: cohort study using the clinical practice research datalink. J Invest Dermatol 135(9):2189\u20132197","journal-title":"J Invest Dermatol"},{"key":"6693_CR57","doi-asserted-by":"crossref","unstructured":"He J et al (2022) Ulcerative colitis increases risk of hypertension in a UK biobank cohort study. United European Gastroenterol J 11(1):19\u201330","DOI":"10.1002\/ueg2.12351"},{"issue":"12","key":"6693_CR58","doi-asserted-by":"crossref","first-page":"1453","DOI":"10.1016\/j.amjmed.2022.08.012","volume":"135","author":"B Chen","year":"2022","unstructured":"Chen B et al (2022) Inflammatory bowel disease and cardiovascular diseases. Am J Med 135(12):1453\u20131460","journal-title":"Am J Med"},{"issue":"3","key":"6693_CR59","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1093\/ecco-jcc\/jjv213","volume":"10","author":"M Harbord","year":"2016","unstructured":"Harbord M et al (2016) The first European evidence-based consensus on extra-intestinal manifestations in inflammatory bowel disease. J Crohns Colitis 10(3):239\u2013254","journal-title":"J Crohns Colitis"},{"issue":"2","key":"6693_CR60","first-page":"115","volume":"58","author":"E Vizzardi","year":"2016","unstructured":"Vizzardi E et al (2016) Subclinical cardiac involvement in Crohn\u2019s disease and ulcerative colitis: an echocardiographic case-control study. Panminerva Med 58(2):115\u2013120","journal-title":"Panminerva Med"},{"issue":"1","key":"6693_CR61","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1111\/j.1440-1746.2006.04384.x","volume":"22","author":"G Bragagni","year":"2007","unstructured":"Bragagni G et al (2007) Cardiac involvement in Crohn\u2019s disease: echocardiographic study. J Gastroenterol Hepatol 22(1):18\u201322","journal-title":"J Gastroenterol Hepatol"}],"container-title":["Clinical Rheumatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10067-023-06693-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10067-023-06693-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10067-023-06693-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,1,8]],"date-time":"2024-01-08T15:06:14Z","timestamp":1704726374000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10067-023-06693-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,7,28]]},"references-count":61,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2024,1]]}},"alternative-id":["6693"],"URL":"https:\/\/doi.org\/10.1007\/s10067-023-06693-7","relation":{},"ISSN":["0770-3198","1434-9949"],"issn-type":[{"value":"0770-3198","type":"print"},{"value":"1434-9949","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,7,28]]},"assertion":[{"value":"26 April 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 June 2023","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 July 2023","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 July 2023","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"None.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Disclosures"}}]}}